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ABSTRACT 
Galectins (Gal) are a family of dimeric lectins, composed by two galactoside-binding sites implicated 
in the regulation of cancer progression and immune responses. In this study, we report for the first 
time the synthesis and the physical-chemical characterization of galectin-1-complex-gold COOH-
terminated polyethlenglicole (PEG)-coated NPs (Gal-1 IN PEG-AuNPs) and their ability to 
recognize glucose in an aqueous solution with a concentration varying from 10 mM to 100 pM. The 
chemical protocol consistsof three steps: (i) complexation between galectin-1Gal-1 and 
tetrachloroauric acid (HAuCl4) to form gold-protein grains; (ii) staking process of COOH-terminated 
polyethlenglicole  molecules (PEG) onto Gal-1-Au complex and (iii) reduction of hybrid metal ions to 
obtain a colloidal stable solution. During the complexation, the spectral signatures related to the Gal-1 
orientation on the gold surface have been found to change due to its protonation state. The effective 
glucose monitoring was detected by UV-Vis, Raman spectroscopy and Transmission Electron 
Microscopy (TEM). Overall, we observed that the interaction is strongly dependent on the Gal-1 
conformation at the surface of gold nanoparticles. 
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Introduction 
Gold-based nanomaterials have been catching much attention in many areas, such as chemistry, 
physics, materials science, and biosciences, because of their size- and shape-dependent optic, electric, 
and catalytic properties[1] [2] [3]. Synthesis of spherical gold nanoparticles (AuNPs) involves the 
chemical reduction of chloroauric acid (HAuCl4) by using sodium borohydride (NaBH4) and sodium 
citrate as the reducing agents, thus lowering particle size up to 2–10 and 10–40 nm, respectively[4] 
[5]. The “green” approach for synthesizing gold nanoparticles (AuNPs) by using natural 
macromolecules has been attracted growing interest over the last few decades[6] [7]. The green natural 
compounds were reported to favour the synthesis of well-dispersed AuNPs [8]. Among screened bio-
macromolecules, proteins have been widely used in nanocluster (< 1 nm) synthesis, hence representing 
ideal candidates for AuNPs  formation[9]. 
In the latest years, Spadavecchia et al. have in-depth investigated the synthesis of hybrid nanoparticles 
based on drugs and/or biomolecules-gold-complex by an experimental approach named “Method IN”, 
in which the drugs or biomolecules interact actively with gold salt (HAuCl4) by chelation bonding. A 
biocompatible polymer molecule (PEG diacid) acts as surfactant, in order to form hybrid gold 
nanoparticles upon reduction by NaBH4 [10-12].  
The same authors have synthetized hybrid metal nanoparticles based on chitosan and on chitosan-
derivatives as sugar stabilizers, for the detection and the tracking of the galectin-1 protein as 
biomarker[13]. Galectin-1 (Gal-1) is a lectin differentially expressed in different tissues, and plays a 
key role in biological systems[14].  It has been recently unveiled that Gal-1 over expression is 
correlated with tumour aggressiveness[15]. Some studies claim the thesis that this protein might 
represent a promising therapeutic marker in cancer[14, 16].  
Some structural studies with Gal-1 have explored its binding to simple carbohydrates, especially 
lactose and N-acetyl-lactosamine [17]. However, it was established that Gal-1 interacts at the cell 
surface with more complex glycans in terms of size and composition[18].  
In this study we provide evidence that, when Gal-1 under gold complex interacts with glucose, its 
solubility increases.Glucose represents the principal energy source in many biological processes, and 
its monitoring as biomarker is important to evaluate human health condition [19].Very careful 
diagnostic methods are impellent required to allow personalized healthcare for active cancer treatment. 
Dyer et al. have described that changes in glucose and glutamine metabolism will be important to 
consider the preclinical evaluation of oncolytic viruses [20]. Recently, a novel technique to detect 
native glucose uptake in tumours has been conceived (http://www.glint-project.eu/).  
Though new instrumental methods for the detection of glucose have been developed [21-24], most of 
methods involving nanoparticles, are also based on enzymes, that can be easily denaturated [25, 26]. 
In particular, nanostructures made of noble metals, such as silver or gold, show strong plasmon 
resonance, which can be detected by the naked eye[22]. The cluster formation results in color change 
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of gold nanoparticle solutions and is correlated with interparticle distance and aggregate size[27]. 
Recently, we demonstrated a novel way to synthesize nanoparticles in which a bio probe was applied 
during the production process [24, 27]. Herein, we report an original methodology to realize spherical 
AuNPs using Gal-1 proteins as stabilizer in one step synthesis and also as an active biomolecular 
probe for glucose interaction monitoring. Synthesis and interaction monitoring have been herewith 
achieved by spectroscopical techniques as Dynamic Light Scattering (DLS), Trasmission Electron 
Microscopy (TEM), Localized Surface Plasmon Resonance (LSPR) and Raman spectroscopy. 
 
Materials and methods 
 
Materials 
Tetrachloroauric acid (HAuCl4), Sodium borohydride (NaBH4), Dicarboxylic PolyEthylene Glycol 
(PEG)-600 (PEG), Sodium Chloride NaCl (0.9%), N-hydroxysuccinimide (NHS), 1-(3-
dimethylaminopropyl)-N’-ethylcarbodiimidehydrochloride (EDC), Phosphate-Buffered Saline (PBS), 
Glucose, Lactose, Galactose and Maltose are all provided by Sigma Aldrich at maximum purity grade. 
Recombinant Human Galectin-1(Lot# 0707271-1) was purchased from PeproTech (Rocky Hill, NJ, 
USA). 
 
Preparation of sugar solutions. 
Glucose, was solubilized at a concentration equal to 1 mg/mL in Milli-Q water (final pH around 3) as 
stock solution, then gradually diluted up to 10mM, 1mM, 100µM, 100nM and 100pM.  
Galactose, lactose  and maltose were treated under the same conditions as controls. 
Preparation of Galectin-1 protein solutions.  
Galectin-1 powder was solubilized in Milli-Q water and then diluted in order to obtain a solution 0.4 
μM as final concentration. 
 
Synthesis PEG-AuNPs  
Colloids PEG-coated AuNPs (PEG-AuNPs) were synthesized by a well-established chemical 
reduction process as described  previously[28]. The PEG-AuNPs obtained were centrifuged two times 
at 9000 rpm for 10 min and dried under nitrogen.  
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Bioconjugation of Gal-1 onto PEG-AuNPs (Gal-1 ON PEG-AuNPs): 
 
Scheme 1 depicts the synthetic procedure for the conjugation of Gal-1 onto PEG-AuNPs surface.  
The binding of Gal-1 onto PEG-AuNPs was performed at pH 7.4 in PBS. Briefly, 20 μL of EDC/NHS 
(80 / 20 mg ratio) aqueous solution were added into 5 mL of PEG-AuNPs. After 1 h, 50 µL (0.4µM) 
of Gal-1 in PBS was added into 2 mL of the reaction mixture and stirred for 2 h at room temperature. 
The Gal-1 ON PEG-AuNPs thus obtained were centrifuged two times at 9,000 rpm for 10 min and 
dried under nitrogen.  
Synthesis of Galectin into PEG-AuNPs (Gal-1 IN PEG-AuNPs): 
Colloids Galectin-PEG coated AuNPs (Gal-1 IN PEG-AuNPs) were synthesized by a chelation 
process depicted in scheme 2. Briefly, 2 mL of Galectin-1 solution (0.4µM) was added to 20 mL of 
tetrachloroauric acid solution (2.4 × 10
−4
 M) under stirring at room temperature for 20 min. Then, 250 
μL of PEG were added into the mixture under magnetic stirring during 10 min. Finally 2 mL of 
aqueous 0.01 M NaBH4 were added drop by drop with precaution until solution turned into a red violet 
color. The Gal-1 IN PEG-AuNPs thus obtained were centrifuged two times at 9,000 rpm for 10 min 
and dried under nitrogen.  
Determination of Gal-1concentration onto (Gal-1 ON PEG-AuNPs ) and into (Gal-1 IN PEG-
AuNPs): 
AuNPs concentration was determined by exploiting standard mathematical calculations in colloidal 
solution as described previously[13].  
Incubation of Gal-1 ON PEG-AuNPs  and Gal-1 IN PEG-AuNPs with Glucose: 
The interaction of Glucose with Gal-1 ON PEG-AuNPs and Gal-1 IN PEG-AuNPs surface was 
achieved through the protocols of incubation described below:  900 µL of Gal-1 ON PEG-AuNPs and 
Gal-1 IN PEG-AuNPs (1mM) were added into separate tubes containing 100 μL of Glucose (from 10 
mM to 100 pM; PBS pH 7; NaCl 0.15 M). After 18 h of incubation, the NPs/Glucose suspension was 
centrifuged twice at 5000 rpm for 10 min to eliminate the excess of Glucose and then the pellets were 
redispersed in 1 mL of Milli-Q water. 
 
Physical-Chemical characterization  
All characterizations were carried out in triplicate determinations as described previously[13, 28, 29]. 
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UV/Vis measurements: 
Absorption spectra were recorded by using a double-beam Varian Cary 500 UV-Vis 
spectrophotometer (Agilent, France). UV-Vis spectra of the NPs were recorded in water at a 
concentration of 1mM in the 200-900 nm spectral range.  
 
Transmission Electron Microscopy (TEM): 
Transmission Electron Microscopy (TEM) images were recorded with a JEOL JEM 1011 microscope 
operating (JEOL, USA) at an accelerating voltage of 100 kV. TEM specimens were prepared after 
separating the surfactant from the metal particles by centrifugation under a protocol described  
elsewhere[28] [21].  
 
Raman Spectroscopy: 
The Raman experiments have been performed on an Xplora spectrometer (Horiba Scientifics-
France)witha protocol described previously[28].  
 
Dynamic light scattering (DLS) and Zeta potential measurements: 
The size and zeta potential measurements were performed by using a Zetasizer Nano ZS (Malvern 
Instruments, Malvern, UK) equipped with a He-Ne laser (633 nm, fixed scattering angle of 173°) at 
room temperature as described previously[28]. 
 
Stability of Gal-1 IN-PEG-AuNPs versus pH: 
The stability of Gal-1 ON-PEG AuNPs was described previously[13], the stability  of Gal-1 IN-
PEGAuNPs was detected by UV-Vis. All nanoparticles were dissolved in PBS solution 10 mM at pH 
5.5 and stored for 3 months (Figure S1 in Supporting Information). 
 
RESULTS AND DISCUSSION 
Functional protein–nanoparticle bioconjugates are gaining increasing attention in biomedical sectors 
such as drug delivery and biosensing[32]. 
Parak et al., have implemented a methodology to obtain protein–gold nanoparticle  bioconjugates with 
a focus on site-specific attachment of protein on AuNPs [9]. The same authors have demonstrated that 
lysine groups are involved during the growth of nanoparticles formation. 
This study aims at explaining the formation of stable complexes of PEGylated Au (III)–Gal-1 as 
building blocks of gold nanoparticles 
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The final goal is to evaluate the  grafting of the Galectin-1 protein (Gal-1) at the surface of the PEG-
AuNPs by carbodiimide chemistry (method ON) and chelation bond (method IN) in order to  study  
the interactions with glucose under  two different chemical conformations. 
 
Conjugation of Gal-1 onto (Gal-1 ON PEG-AuNPs)  and into (Gal-1 IN PEG-AuNPs) PEG-
AuNPs :  
Previously, Spadavecchia et al. have grafted pegylated gold nanoparticles (PEG-AuNPs) with 
biomolecules by several chemical methodologies in order to evaluate therapeutic efficiencies[13] [27] 
[10] [30]. Huang et al. adsorbed galectin-1 molecules onto citrate gold nanoparticles by an 
electrostatic approach in order to increase protein binding affinity to receptors by cross-linking CD45 
on T cells[31]. 
Herein we designed and characterized the grafting of Gal-1 at the surface of the pegylated gold 
nanoparticles through the formation of amide links between the -COOH groups embedding the surface 
of the PEG-AuNPs and the -NH2 groups of the protein by activation with EDC/NHS (method ON) 
(scheme 1).  
 
 
 
 
Scheme 1: Schematic representation of the Gal-1 conjugation onto PEG-AuNPs (Gal-1 ON PEG-
AuNPs) (Please note that drawings are not in scale and are not intended to be representative of the full 
samples composition). 
 
 
The protocol used for the production of Gal-1 IN PEG-AuNPs involves the formation of Au (III)-Gal-
1 complexes (Gal-1-AuCl4
-
), followed by PEG interactions with Gal-1-AuCl4
-
 clusters and formation 
of AuNPs. To the best of our knowledge, examples of AuNPs formation from stable Au
3+
 ions-Gal-1 
complexes cannot be found in the scientific literature (method IN) (scheme 2).  
 
EDC/NHS
Carbodiimide
binding
Gal-1
NH2
Au
Gal-1 ON PEG-AuNPsPEG-AuNPs
Au
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Scheme 2.Representation of the synthesis of Gal-1 IN PEG-AuNPs (Please note that drawings are not 
in scale and are not intended to be representative of the full samples composition). 
 
The aim of this paper is to assess the interactions between Gal-1 and glucose under formation of stable 
complexes of PEGylated Au(III) as active excipients of gold nanoparticles. The major discrepancy 
with other chemical procedures is that in our study Gal-1 participates to the nucleation and growth of 
AuNPs via complexation between the ketone of Asn 50 and the amino groups of phenylalanine side 
chains (Phe39, Phe49, Phe126)[32] with chloride auric ions. In our case, the formation of gold NPs 
from AuCl4
-
comprehendsthe following steps (scheme 2): 
(1) Chelation of Gal-1 with AuCl4
-
 and inceptive reduction of the protein-metal complex to 
produce gold clusters; 
(2) Embedding process of PEG by electrostatic adsorption onto the Gal-1gold clusters; 
(3) Final reduction of metal ions and growth of a stable colloidal solution (AuNPs) through 
dicarboxylic PEG polymers. 
In the first step, Gal-1 is added into HAuCl4 aqueous solution to complex with him. In the second step, 
the PEG polymer chains diacide in water solution embedding  a complex Gal-1-AuCl4
-
,plays a key 
role in the growth process of AuNPs [33]. The addition of PEG in the Gal-1-AuCl4
-
solution improves 
the reduction kinetics through complexation with the Au ions [34]. This effect regulates the 
simultaneous chemical and steric arrangement of Gal-1 and PEG between AuCl4
-
 on the surface of 
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gold seeds during the growth of nanoparticles. In the third step, the final reduction of metal ions in the 
presence of NaBH4, generates the hybrid nanoparticles . 
 
Physicochemical evaluation of  Gal-1 ON PEG-AuNPs   and Gal-1 IN PEG-AuNPs:  
 
The interaction between Gal-1 and PEG-AuNPs was monitored by UV-Vis absorption spectra.  
Figure 1 A shows the localized surface plasmon (LSP) band of PEG-AuNPs before (Figure 1A, blue 
line) and after immobilization of Gal-1 by carbodiimide chemistry (Gal-1 ON PEG-AuNPs) (Figure 
1A, black line). After immobilization of Gal-1 onto PEG-AuNPs (Gal-1 ON PEG-AuNPs) the colour 
of the solution changes and the colloidal solution was characterized by UV-Vis spectroscopy. The 
Gal-1 ON PEG-AuNPs showed a broad LSP peak at 548 nm, due to the change of localized refractive 
index of PEG-AuNPs [28]. The notable red-shift of the LSP band with a peak broadening in the Gal-1 
ON PEG-AuNPs spectra, indicate a linear increase in particle size and modification of the 
nanoparticles surface[35]. Based on the UV-Vis spectrum of Gal-1 ON PEG-AuNPs, we assume that 
such increase could be associated to the successful conjugation of the AuNPs surface with Gal-1, and 
the ulterior AuNPs agglomeration associated to the formation of classical van der Waals inter-protein 
interactions [28]. 
Concerning the chelation method (method IN), we observed a blue-shift from 548 nm to 538 nm 
(Figure 1A, red line),due to π-π* electronic transitions between the Gal-1 and AuCl4
- 
ions [11],giving 
a common demonstration of the complex formation. The different shift of the plasmon band, indicate 
that each chemical protocol applied (ON and IN) is answerable of different chemical behavior of the 
Gal-1 from PEG-AuNPs. This will have remarkable impacts on the steric conformation of the Gal-1 at 
the PEG-AuNPs surface and distinct grafting kinetic. Infact, the chemical grafting will impact the 
steric place of the Gal-1. In the case of the carbodiimide grafting (EDC/NHS), the Gal-1 is situated 
directly at the gold surface embedded by a PEG layer while for the chelation method, the Gal-1 will be 
placed into the core of gold, surface folded of the PEG layer. This chemical attitude is due to a specific 
adsorption onto cristallographic gold facets [1.1.0] of Gal-1,that allows a different steric conformation 
of chemical groups during nucleation and growth process of PEG-AuNPs. This behavior was 
confirmed by TEM Images.  
Figure 1B  displays a spherical pegylated gold nanoparticles showing a diameter of about 10± 2, in 
nice agreement with what observed previously [28]. After carbodiimide grafting, the Gal-1 ON PEG-
AuNPs appears as circular agglomerate of nanoparticles decorated of a dense layer of polymer. 
Though the size of single protein was about 5 nm [36], we believe that Gal-1 takes a better place of 
PEG molecules onto the particles, with a specific steric arrangement. On the contrary, the shape of 
Gal-1 ON PEG-AuNPs, Gal-1 IN PEG-AuNPs displays spherical gold nanoparticles, piled in a shell of 
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PEG, with an almost analogous diameter of around 30 ± 2 nm (Figure 1B). The Gal-1grafting is 
confirmed by DLS and Zeta potential measurements (Table 1). The hydrodynamic diameter is 
increased by around 10 nm, which means an increase of 5 nm of the hydrodynamic diameter. 
Furthermore, Zeta potential measurements display a straight forward negative surface charge, 
indicating that colloids are expected being stable at physiological pH (Table 1). 
Table 1: z-potential and hydrodynamic diameter of PEG-AuNPs , Gal-1 ON PEG-AuNPs and Gal-1 
IN PEG-AuNPs by carbodiimide and chelation chemistry. 
Synthetic product 
Zeta potential 
(mV) 
Hydrodynamic 
diameter 
(nm) 
PDI 
 PEG-AuNPs -22 ± 1 10 ± 2 0.3± 2 
 Gal-1 ON PEG-AuNPs 
 Gal-1 IN PEG-AuNPs 
-28 ± 1 
-33 ± 1 
15 ± 3 
30± 2 
0.3± 2 
0.3± 2 
 
The stability of Gal-1 AuNPs in solution, was monitored by the Localized Surface Plasmon (LSP) 
band at 548nm (Gal-1 ON PEG-AuNPs) and 538 nm (Gal-1 IN PEG-AuNPs). The analysis was 
carried out at pH 5.5 and electrolytic conditions. The synthesized Gal-1 IN PEG-AuNPs did show an 
almost negligible change in the LSP band position over a period of three months (Figure S1 in the 
Supporting Information). Some differences in term of LSP were observed between Gal-1 ON PEG-
AuNPs and Gal-1 IN PEG-AuNPs, due to the different chemical behavior of Gal-1as function of size 
and shape respectively. 
11 
 
  
 
Figure 1: (A) Normalized UV-Vis absorption spectrum of PEG-AuNPs (blue line), Gal-1 ON PEG-
AuNPs (black line), Gal-1 IN PEG-AuNPs (red line) in the spectral range (400-900nm). (B) TEM 
images of PEG-AuNPs before  and after conjugation of Gal-1 protein by carbodiimide chemistry (Gal-
1 ON PEG-AuNPs) and chelation reaction (Gal-1 IN PEG-AuNPs ) Scale bars: 50 nm; 10 nm. (C)  
Raman spectra of the Gal-1 IN PEG-AuNPs (red line) and Gal-1 ON PEG-AuNPs Experimental 
conditions: λexc = 785 nm; laser power 20 mW; accumulation time 180 s. 
 
 
The Raman spectra of Gal-1 ON PEG-AuNPs (black line) and Gal-1 IN PEG-AuNPs (red line) 
(Figure 1-C) in water exhibit many bands in the region 200-2000 cm
-1
.One of the Raman fingerprint 
of the Gal-1 IN PEG-AuNPs is the presence of a band around 263 cm
-1
 and a double peak at 522-430 
cm
-1
. These bands can be assigned to the gold chloride stretches, ν (Au-Cl), and δ (O-Au-O) in 
aliphatic chains, and is a clear evidence of the formation of a complex between AuCl2
-
, PEG and Gal-1 
in solution. The common peak at 430 cm
-1
 is due to the vibrations δ (OH…O), ν (OH…O) of the PEG. 
Based on the spectrochemical and previously theoretical results, we assumed that Au
3+
 ions promoted 
the deprotonation of the PEG[11] in the presence of Gal-1. The spectra of PEG molecules free as 
control was previously described in literature [13, 37]. Only few bands remain as the two bands 
around 1000 cm
-1
 and the one around 1620 cm
-1
. The strong band at 1375 cm
-1
 is assigned to C=O 
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carbonyl stretching of PEG-Gal-1and a double peak at 1045-1181 cm
-1
 is due to C-O-C stretching in 
backbone of PEG after  stacking onto gold nanoparticles. Furthermore, new bands also appear as an 
intense triplet at 1211-1243-1289 cm
-1
 due to C-O plane deformation of carboxylic acid and a strong 
peak at 1471 cm
-1
 and 1616 cm
-1
 assigned to ν C-O-O stretching and amide II band with a small peak 
at 1584 cm
-1
 due to symmetric N-H stretching. In contrast, Gal-1 ON PEG-AuNPs showed Raman 
bands due to the presence of water and of the PEG molecules onto the gold surface of nanoparticles. 
Some news bands around 800-900 cm
-1
 appeared, confirming a different Gal-1 orientation onto 
AuNPs compared to Gal-1 IN-PEG-AuNPs. The main difference consists in the bands located on the 
range 1400-1500 cm
-1
. The band at 1464 cm
-1
 confirms the amide band between dicarboxylic PEG 
molecules onto AuNPs and amino group of Gal-1.All these differences of bands are due to the 
variation of the steric conformation of the polymers and Gal-1 upon complexation. 
Physicochemical evaluation of Galectin-1/Glucose Interaction:  
It was proved that Gal-1 binding to carbohydrates cross-links adjacent glycoconjugates to mediate 
biological activity[32]. Despite individual binding interactions with carbohydrates are weak[18], 
ligands for galectin-1 typically possess an array of carbohydrates to enhance the binding affinity[32]. 
In a previous paper[13], we proved the successful of the interaction between a branched polymer 
lactose-modified chitosan (CTL) with pegylated gold nanoparticles (PEG-AuNPs) and Gal-l.  
Gal-1 binds relatively strongly to CTL, and CTL-PEG AuNPs showed a  calculated affinity constant 
(1 x 10
5
 M
-1
) stronger than that reported in literature by Miller et al. [17]. For these reasons, we 
developed a novel methodology in which galectin-1 complexed to AuNPs, interacts rectly with 
carbohydrates (i.e. glucose) without chemical intermediate. In latest years, the detection of glucose 
with nanoparticles has attracted great interest for their optical properties[38].Previously, we described 
a novel synthesis of nanoparticles, in which Vmh2 protein class I of hydrofobin HFB from P. 
ostreatus, was exploited as original biomolecular probe in glucose with an affinity constant of 
7.3±0.3mg mL
−1
, corresponding to about 40 mM. Liu et al. have developed a quantitative colorimetric 
immunoassay based on glucose oxidase (GOx)- of 5 nm AuNPs that can detect prostate-specific 
antigen (PSA) cancer biomarkers from atto- to pico-molar levels[39]. 
In this study we present a novel methodology in order to detect the concentration of glucose under nM, 
in order to generate diagnostic bio-markers based on Galectin-1 protein. 
For this purpose, Gal-1 PEG-AuNPs was used as building blocks to detect the biomolecular 
interaction with glucose. The glucose interaction with Gal-1 PEG-AuNPs was evaluated by UV-
visible absorption (Figure 2) and Raman spectroscopy (Figure 5). 
When Glucose was added to a colloidal solution of Gal-1 IN PEG-AuNps in the range from 10 mM to 
100 pM, we observed a dynamic variation of LSP band and a dramatic color change after 15 min 
depending on the glucose amount (Figure 2A-B). Lowering the concentration of glucose from 10 mM 
to 1 mM, a plasmon band red-shifted from 538 nm to 549 nm. This weak red shift of the plasmon 
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band, can be explained by a lower nanoparticle aggregation and a dissociation of agglomerates after 
the addition of glucose at a concentration of 1 mM (Figure  2A-B-C). It means that from 10 mM up to 
1 mM, glucose interacts with the Gal-1 IN PEG-AuNPs inducing very small changes on the plasmon 
band (modification of the dielectric constant around the AuNPs with the addition of Gal-1 proteins and 
maybe few dissociations). At concentrations lower than 1 mM, a large number of glucose molecules 
interacts with the Gal-1 IN PEG-AuNPs forming a glucose monolayer at the AuNPs surface. At 100 
µM we observed a formation of a broadened band at 748 nm due to the formation of cross-links 
between Gal-1 IN PEG-AuNPs and glucose. When the concentration of glucose decreases from 100 
µM to 100 nM the resulting solution was colorless, with a decrease in the UV-Vis spectrum intensity 
and a red-shift of around 20 nm (from 748 nm to 761 nm). A further decrease of the plasmon at 100 
pM of glucose could be attributed to the change of localized refractive index near the NPs surface of a 
substantial amount of plasmonic coupling, indicating that the glucose was conjugated to the Gal-1 IN 
PEG-AuNPs surface. We thus conclude that the selectively interacts with the Gal-1 IN PEG-AuNPs 
surface. The evolution of the Gal-1 IN PEG-AuNPs plasmonic bands versus the Gal-1 concentration is 
displayed in Figure 2-C. 
The experiments carried out with Gal-1 ON PEG-AuNPs in order to evidence the selective binding  of 
Gal-1 with glucose, , did not revealed any remarkable spectroscopical modification of plasmonic 
bands (Figures 3A-B).  
 
Figure 2. A) UV-Vis absorption spectra in the range 400-900 nm of Gal-1 IN PEG-AuNPs before 
(black line) and after interaction of glucose (from 10 mM to 100 pM); B) Zoom of UV-Vis absorption 
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spectra in the range 400-600 nm of Gal-1 IN PEG-AuNPs before and after interaction of glucose. C) 
Dynamic evolution of the Gal-1 IN PEG-AuNPs plasmonic bands versus the glucose concentration. 
 
 
Figure 3. A) UV-Vis absorption spectra in the range 400-900 nm of Gal-1 ON PEG-AuNPs before 
(black line) and after interaction of glucose (from 10 mM to 100 pM);B) Dynamic evolution of the 
Gal-1 ON PEG-AuNPs plasmonic bands versus glucose concentration. 
 
For Gal-1 IN PEG-AuNPs, the formation of cross-links with glucose were further verified both by 
visual observations and by TEM analysis. We detected a pinkish-red color to the naked eye (Figure 4 
panel A) and NPs with a characteristic spherical shape at 0 mM of glucose (Figure 4-panel B inset 
1). The addition of 10 mM concentrations of glucose resulted in a slightly more purple color than the 
initial Gal-1 IN PEG-AuNPs conjugate. We assumed that at 10mM, the galactoside-binding sites of 
galectin-1 have been saturated by glucose molecules, the latter forming a thin layer at the surface of 
nanoparticles. This prevents the link of nanoparticles to form some nanoclusters. When the 
concentration of glucose decreased at 1mM, we observed a dramatic color change from red to purple 
with characteristic linear chains of gold nanoparticles (Figure 4- panel B inset 2). This behaviour is 
probably due to more galactoside-binding sites available with ensuing formation of nanoclusters 
between glucose the galectin-1 into nanoparticles [40] (Figure 4 panel B).When the glucose 
concentration was decreased from 100 µM to 100 pM, the color appeared to turn a purple grey color, 
and grew progressively transparent at concentrations of 100 pM with a consequent agglomeration of 
nanoparticles-conjugates until precipitation  (Figure 4-panel B inset 3-4). This optical behaviour is 
opposite to a previous study, in which glucose was monitored in the presence of collagen-gold 
nanoparticles with a limit of detection of 0.18 mM [41]. In our case, the presence of galectin-1 
complexed onto gold nanoparticles, improve the glucose interaction due to their better steric and 
chemical configuration. 
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Figure 4.A) Optical color change at different concentration of glucose and schematic mechanism of 
glucose interaction onto Gal-1 IN PEG-AuNPs; B) TEM images of Gal-1 IN PEG-AuNPs before (1) 
and after interaction of glucose (2-3-4). Scale bars: 100 nm; 20 nm (Please note that drawings are not 
in scale and are not intended to be representative of the full samples composition). 
 
The successful interaction of glucose onto Gal-1 IN PEG-AuNPs surface was established by Raman 
spectroscopy at different glucose concentrations (10 mM-100 pM ) (Figure 5).The fingerprint 
detection of glucose onto Gal-1 IN PEG-AuNPs surface was demonstrated through the appearance of 
the Raman bands and SERS effect at 1250 cm
-1
, 1472 cm
-1
 and 848 cm
-1
due to the vibration of C-O-H, 
C-O-C and C-O chemical groups, respectively (Figure 5). 
After the glucose interaction, 550-610 cm
-1 
the amide II (1587-1620 cm
- 1
) and amide III (1200-1300 
cm
- 1
 regions), as well as modifications in protein local environments, confirmed the protein 
interaction [42] .  
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Figure 5. A) Raman spectra of the Gal-1 IN PEG-AuNPs before (black line) and after interaction of 
glucose (glucose concentration range 10 mM - 100 pM); directional arrows show the characteristic 
peaks during glucose interaction. Experimental conditions: λexc = 785 nm; laser power 20 mW; 
accumulation time 180 s. 
 
By evaluating the Raman results it is possible to confirm that the chemical and steric conformation of 
Gal-1 influences the detection of glucose onto Gal-1 IN PEG-AuNPs, when Gal-1 is complexed to 
gold salt. In fact, the interaction of glucose on the Gal-1 IN PEG-AuNPs will take place due to their 
great packing density as well as to the forces repulsion between the negatively charged Gal-1.Similar 
analyses of interaction (UV-Vis and Raman) were carried out in the presence of PEG-AuNPs as 
control, under the same experimental conditions, confirming the selectivity of interaction betweenGal-
1 IN PEG-AuNPs and glucose. Infact, after incubating PEG-AuNPs and glucose at maximal 
concentration (10mM), we did not observe any signal variation as described previously [27]. 
 
Selectivity of Gal-1 IN PEG-AuNPs towards glucose: 
To confirm the selectivity of Gal-1 IN PEG-AuNPs versus glucose, a preliminary test in the presence 
of galactose, lactose and maltose were carried out. The interaction between Gal-1 IN PEG-AuNPs 
galactose, lactose and maltose was monitored by UV-Vis and Raman spectroscopy (Figure S2 in 
Supporting Information), and did not show any remarkable spectroscopical modification. This 
means that there was no capture of the galactose, lactose and maltose at the Gal-1 IN PEG-AuNPs 
surface even at high concentration of sugar. We thus can conclude that the Gal-1 IN PEG-AuNPs 
surface selectively interacts with glucose. 
 
 
 
Gal-1 IN PEG-AuNPs
10 mM Glucose
1 mM Glucose
100 µM Glucose
100 nM Glucose
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Conclusions 
In the present work Galectin-1 (Gal-1) was exploited as both a stabilizer of a nano-biosystem and an 
active biomolecular probe in glucose monitoring in order to evaluate further human health 
diseases. All experimental results highlighted that Gal-1IN PEG AuNPs manifested , for the first 
time, the ability to bind glucose even if intrinsically engaged with a gold complex by chelation 
methodology. In essence, a new hybrid bio/non-bio nanosystem was developed for both interface 
stabilization and biomolecular interaction monitoring applications. Indeed, in the second time, 
news galectin-1 nanoformulations will be internalized in pancreatic cancer cells to detect 
the glucose produced under specific conditions.  This study not only provides a new 
colorimetric assay for the simple detection of glucose for specific applications, e.g. predicted 
cancer and treatment, but also potentially offers a new analytical platform for understanding 
the molecular basis of physiological and pathological events. 
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